Straits Times Index
3,290.70 +24.75 (+0.76%) Nikkei
38,229.11 +155.13 (+0.41%) Hang Seng
18,963.68 +425.87 (+2.30%) FTSE 100
8,433.76 +52.41 (+0.63%) Bitcoin USD
60,867.54 -2,015.52 (-3.21%) CMC Crypto 200
1,261.28 -96.72 (-7.12%)
HLS Therapeutics Inc. (HLTRF)
| Previous close | 3.4500 |
| Open | 2.9200 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 2.9200 - 2.9200 |
| 52-week range | 2.6000 - 4.9494 |
| Volume | |
| Avg. volume | 92 |
| Market cap | 96.389M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.8500 |
| Earnings date | 08 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | 0.15 (4.21%) |
| Ex-dividend date | 27 Apr 2023 |
| 1y target est | N/A |
Simply Wall St.An Intrinsic Calculation For HLS Therapeutics Inc. (TSE:HLS) Suggests It's 44% Undervalued
Key Insights HLS Therapeutics' estimated fair value is CA$8.53 based on 2 Stage Free Cash Flow to Equity HLS...
CNW GroupHLS Therapeutics Announces Q1 2024 Financial Results
HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), a pharmaceutical company focused on addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease, announces its financial results for the three-month period ended March 31, 2024. All amounts are in thousands of United States ("U.S.") dollars unless otherwise stated.
CNW GroupHLS Therapeutics to Host Q1 Fiscal 2024 Financial Results Conference Call
HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), announces that it will release its Q1 fiscal 2024 financial results on Thursday, May 9, 2024. The Company will hold a conference call that same day at 8:30 a.m. ET to discuss its results. The call will be hosted by Mr. Craig Millian, Chief Executive Officer and Mr. John Hanna, Interim Chief Financial Officer. Slides to accompany management's prepared remarks will be available to view via the webcast.
